Francisco Silva
2021
In 2021, Francisco Silva earned a total compensation of $21.3M as VP, Research and Development at BioRestorative Therapies, a 10,175% increase compared to previous year.
Compensation breakdown
| Option Awards | $14,081,677 |
|---|---|
| Salary | $259,375 |
| Stock Awards | $6,984,812 |
| Total | $21,325,864 |
Silva received $14.1M in option awards, accounting for 66% of the total pay in 2021.
Silva also received $259.4K in salary and $7M in stock awards.
Rankings
In 2021, Francisco Silva's compensation ranked 288th out of 12,415 executives tracked by ExecPay. In other words, Silva earned more than 97.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 288 out of 12,415 | 98th |
Division Services | 110 out of 2,290 | 95th |
Major group Health Services | 12 out of 252 | 95th |
Industry group Miscellaneous Health And Allied Services, Not | 2 out of 32 | 94th |
Source: SEC filing on September 23, 2022.
Silva's colleagues
We found two more compensation records of executives who worked with Francisco Silva at BioRestorative Therapies in 2021.
News
BioRestorative Therapies CEO Lance Alstodt's 2023 pay jumps 177% to $1.3M
August 8, 2024
BioRestorative Therapies CEO Lance Alstodt's 2022 pay falls 98% to $452K
August 4, 2023
BioRestorative Therapies CEO Lance Alstodt's 2021 pay jumps 33,082% to $21M
September 23, 2022
BioRestorative Therapies Senior VP, Planning and Business Development Adam Bergstein receives $1.8M in 2018
April 18, 2019